Correlation Between Anika Therapeutics and NuVasive

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Anika Therapeutics and NuVasive at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anika Therapeutics and NuVasive into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anika Therapeutics and NuVasive, you can compare the effects of market volatilities on Anika Therapeutics and NuVasive and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anika Therapeutics with a short position of NuVasive. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anika Therapeutics and NuVasive.

Diversification Opportunities for Anika Therapeutics and NuVasive

-0.31
  Correlation Coefficient

Very good diversification

The 3 months correlation between Anika and NuVasive is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Anika Therapeutics and NuVasive in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NuVasive and Anika Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anika Therapeutics are associated (or correlated) with NuVasive. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NuVasive has no effect on the direction of Anika Therapeutics i.e., Anika Therapeutics and NuVasive go up and down completely randomly.

Pair Corralation between Anika Therapeutics and NuVasive

Given the investment horizon of 90 days Anika Therapeutics is expected to under-perform the NuVasive. In addition to that, Anika Therapeutics is 1.36 times more volatile than NuVasive. It trades about -0.03 of its total potential returns per unit of risk. NuVasive is currently generating about 0.0 per unit of volatility. If you would invest  4,279  in NuVasive on August 28, 2024 and sell it today you would lose (44.00) from holding NuVasive or give up 1.03% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy28.78%
ValuesDaily Returns

Anika Therapeutics  vs.  NuVasive

 Performance 
       Timeline  
Anika Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Anika Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's forward indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
NuVasive 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NuVasive has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, NuVasive is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Anika Therapeutics and NuVasive Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Anika Therapeutics and NuVasive

The main advantage of trading using opposite Anika Therapeutics and NuVasive positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anika Therapeutics position performs unexpectedly, NuVasive can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NuVasive will offset losses from the drop in NuVasive's long position.
The idea behind Anika Therapeutics and NuVasive pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance